LG 101506: Precision RXR Modulator for Nuclear Receptor S...
LG 101506: Precision RXR Modulator for Nuclear Receptor Signaling Research
Executive Summary: LG 101506 is a chemically defined small molecule RXR modulator with 98% purity, suitable for mechanistic studies of nuclear receptor signaling (APExBIO). RXR pathways are critical for regulating metabolism and immune responses in mammalian cells (Zhang et al., 2022). LG 101506 demonstrates superior solubility in DMSO (42.05 mg/ml) and ethanol (21.03 mg/ml), enabling robust workflow compatibility. Recent studies link RXR modulation to immune checkpoint control and tumor microenvironment reprogramming, underscoring LG 101506's value in cellular and disease models. APExBIO's B7414 kit provides researchers with reliable, research-grade material for advanced RXR signaling investigations.
Biological Rationale
Retinoid X Receptors (RXRs) are nuclear receptors that form functional heterodimers with other nuclear receptors, impacting gene transcription in metabolism, inflammation, and cell fate determination (Zhang et al., 2022). Dysregulation of RXR signaling is implicated in metabolic diseases, cancer, and immune evasion. Modulating RXR with selective ligands such as LG 101506 allows precise dissection of nuclear receptor pathways and post-translational modifications relevant to both basic and translational research (see here). Unlike broad-spectrum retinoids, LG 101506 offers targeted RXR modulation, reducing off-target effects and facilitating studies in nuclear receptor-related disease models. This approach extends prior work by providing a tool for interrogating RXR's role in immune-cold tumor microenvironments, complementing research on immune checkpoint regulation.
Mechanism of Action of LG 101506
LG 101506, with the chemical name (2E,4E,6Z)-7-(3,5-di-tert-butyl-2-(2,2-difluoroethoxy)phenyl)-3-methylocta-2,4,6-trienoic acid, binds selectively to the RXR ligand-binding domain. This binding induces conformational changes in RXR, modulating its transcriptional activity as a heterodimeric partner with other nuclear receptors (e.g., PPARs, LXR, FXR). The downstream effect is altered expression of RXR-responsive genes, impacting metabolic regulation, cell cycle progression, and immune checkpoint expression (Zhang et al., 2022). Mechanistic studies reveal that RXR modulation can influence PD-L1 stability and function via indirect signaling cascades, intersecting with the regulation of immune cell infiltration and T cell-mediated cytotoxicity in tumor models (see mechanistic analysis). LG 101506 thus serves as a precision tool for dissecting these regulatory axes.
Evidence & Benchmarks
- LG 101506 exhibits high chemical purity (98.00%) as verified by HPLC and mass spectrometry (APExBIO certificate; product page).
- Solubility: 42.05 mg/ml in DMSO, 21.03 mg/ml in ethanol at 25°C, enabling compatibility with in vitro and cell-based assays (APExBIO).
- RXR signaling is implicated in immune checkpoint regulation, including PD-L1 stability and glycosylation, which affects anti-tumor immunity (Zhang et al., 2022).
- Modulation of RXR alters transcriptional networks governing metabolism and immune cell recruitment in the tumor microenvironment (internal review).
- Combination of RXR pathway targeting with immune checkpoint blockade enhances anti-tumor T cell responses in experimental models (Zhang et al., 2022).
Applications, Limits & Misconceptions
LG 101506 is designed for research applications targeting RXR signaling in metabolism and cancer biology. It is particularly valuable for:
- Modeling RXR function in metabolic regulation and nuclear receptor crosstalk.
- Dissecting the impact of RXR modulation on immune checkpoint proteins in tumor microenvironments.
- Enabling advanced studies in nuclear receptor-related disease models, including immune-cold cancers.
This article expands on prior reviews such as 'LG 101506: RXR Modulator Empowering Nuclear Receptor Rese...' by providing updated evidence on RXR's interaction with immune checkpoint pathways. It also extends the mechanistic discussions found in 'Rewiring RXR Signaling: Strategic Leverage of LG 101506 f...' by detailing LG 101506's specific workflow integration and quantitative performance benchmarks.
Common Pitfalls or Misconceptions
- Not for Clinical Use: LG 101506 is for research use only; it is not approved for diagnostic or therapeutic applications (APExBIO).
- Long-Term Solution Stability: Prepared solutions of LG 101506 are unstable over extended periods; use promptly after preparation.
- Off-Target Effects: While selective for RXR, supraphysiological concentrations may result in off-target modulation of other nuclear receptors.
- Species and Cell-Type Differences: RXR signaling effects can vary by model system; benchmark in context.
- Temperature Sensitivity: Compound must be stored at -20°C to maintain integrity; avoid repeated freeze-thaw cycles.
Workflow Integration & Parameters
LG 101506 is provided as an off-white solid by APExBIO (B7414). It is soluble up to 42.05 mg/ml in DMSO and 21.03 mg/ml in ethanol at room temperature. For experimental use, dissolve in DMSO, aliquot, and store at -20°C. Avoid prolonged storage of aliquoted solutions. For cell-based assays, dilute freshly in compatible buffers or media immediately before use. The compound is shipped with blue ice or dry ice, depending on format, to preserve stability. Detailed protocols for nuclear receptor signaling assays, standard concentrations, and handling precautions are provided in the APExBIO datasheet (LG 101506 product page).
Conclusion & Outlook
LG 101506 stands as a robust and validated RXR modulator for nuclear receptor signaling research. Its high purity, solubility, and workflow compatibility enable advanced studies in metabolism regulation, immune checkpoint biology, and cancer models. Ongoing research is expected to further elucidate RXR's role in immune modulation and disease, with LG 101506 facilitating mechanistic and translational breakthroughs. For researchers seeking to advance the field of chemical biology of RXR and investigate novel combinatorial strategies in nuclear receptor-related disease models, LG 101506 offers a precision tool with strong experimental grounding (APExBIO).